Cellosaurus cell line CHIpMSC1 (CVCL

Cellosaurus CHIpMSC1 (CVCL_B3MQ)

[Text version]

Cell line name

CHIpMSC1

Synonyms

F-CHI

Accession

CVCL_B3MQ

Resource Identification Initiative

To cite this cell line use: CHIpMSC1 (RRID:CVCL_B3MQ)

Comments

Derived from site: In situ; Pancreas; UBERON=UBERON_0001264.
Cell type: Mesenchymal stem cell; CL=CL_0000134.

Sequence variations

Mutation; HGNC; HGNC:59; ABCC8; Simple; p.Gly316Arg (c.946G>A); ClinVar=VCV001687413; Zygosity=Heterozygous (PubMed=31525223).

Disease

Persistent hyperinsulinemic hypoglycemia of infancy (NCIt: C122923)
Autosomal dominant hyperinsulinism due to SUR1 deficiency (ORDO: Orphanet_276575)

Species of origin

Homo sapiens (Human) (NCBI Taxonomy: 9606)

Sex of cell

Male

Age at sampling

Category

Somatic stem cell

STR profile

Source(s): CelloPub=CLPUB00652

Markers:

Amelogenin	X,Y
CSF1PO	11,13
D3S1358	14,18
D5S818	11,12
D7S820	11
D8S1179	13,15
D13S317	8,12
D16S539	12
D18S51	12
D21S11	27,29
FGA	19,21
Penta D	9,12
Penta E	7,12
TH01	7,9.3
TPOX	10,11
vWA	14

Publications

CLPUB00652
Kellaway S.G.
Stem cells from patients with congenital hyperinsulinism.
Thesis PhD (2016); University of Manchester; Manchester; United Kingdom

PubMed=31525223; DOI=10.1371/journal.pone.0222350; PMCID=PMC6746350
Kellaway S.G., Mosinska K., Mohamed Z., Ryan A., Richardson S.M., Newbould M., Banerjee I., Dunne M.J., Cosgrove K.E.
Increased proliferation and altered cell cycle regulation in pancreatic stem cells derived from patients with congenital hyperinsulinism.
PLoS ONE 14:E0222350-E0222350(2019)

Cross-references

Encyclopedic resources

Wikidata; Q110432706

Entry history

Entry creation

16-Dec-2021

Last entry update

19-Dec-2024

Version number